EUVIMEDEUVIMED entdecken
Crossref

miR ‐619‐5p and cardiogenic shock in patients with ST‐segment elevation myocardial infarction

Rafael Escate iD, Teresa Padró iD, Rosa Suades iD, Jordi Sans-Roselló, Yvan Devaux iD, Päivi Lakkisto iD, Veli-Pekka Harjola, Alessandro Sionis iD, Lina Badimon iD

European Journal of Clinical Investigation · 2024

DOI: 10.1111/eci.14186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Rafael Escate und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular-Program ICCC, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain. Hauptthemen laut MEDLINE: Shock, Cardiogenic, MicroRNAs, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Agencia Estatal de Investigación, Instituto de Salud Carlos III, Spanish Society of Cardiology (SEC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiogenic shock (CS) is a severe myocardial dysfunction secondary to various cardiac conditions including ST‐segment elevation acute myocardial infarction (STEMI) and associated with a high risk of death. Little is known on epigenetic determinants in CS. Here, we investigated plasma miRNAs in relation to CS stratification in STEMI‐patients.

Methods

STEMI‐patients ( n = 49), with (CS, n = 25) and without CS (non‐CS, n = 24) fulfilling inclusion criteria were included from HSCSP‐cohort (Derivation‐cohort). CS‐miRNAs were analysed by Affymetrix‐microarray and RT‐PCR. Results were validated in a second cohort of CS‐patients (CardShock: n = 35) with similar inclusion/exclusion criteria as the derivation cohort. In silico analysis were performed to identify potential miRNA target genes.

Results

Of the 5‐miRNA signature obtained from microarray analysis, miR‐619‐5p showed higher levels in CS than in Non‐CS patients ( p = .003) and discriminating power for CS by ROC (AUC: .752, p = .003). miR‐619‐5p directly associated with risk scores [GRACE, p = .001; CardShock, p < .001]. Furthermore, miR‐619‐5p showed discrimination power for death in CS. Thus, miRNA levels were significantly higher in patients with mortality outcome both in the Derivation HSCSP‐cohort ( p = .02; AUC: .78 ± .095) and the Validation CardShock‐cohort ( p = .017; AUC: .737 ± .086) By in silico analysis, miR‐619‐5p target genes and TNF‐alpha were involved in the regulation of inflammation. miR‐619‐5p and TNF‐alpha levels discriminated mortality outcome in CS‐patients during 30‐day follow‐up (Validation‐Cohort: ROC: .812, p = .002; HR: 9.99, p = .003).

Conclusions

Up‐regulation of miR‐619‐5p is found in the plasma of STEMI‐patients with CS and mortality outcome. These findings highlight the specificity of epigenetic regulation of inflammation on the disease severity of MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, CardiogenicMicroRNAsST Elevation Myocardial InfarctionHumansMaleFemaleMiddle AgedAgedROC Curve

Stichwörter der Autor:innen

cardiovascular diseaseepigeneticinflammatory responsemortality riskplasma miRNAs

Substanzen

MicroRNAsMIRN619 microRNA, human

Autor:innen und Institutionen

  • Cardiovascular-Program ICCC, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain.
  • Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.
  • Cardiology Department, Parc Taulí Hospital Universitari, Sabadell, Spain.
  • Cardiovascular Research Unit, Luxembourg Institute of Health, Strassen, Luxembourg.
  • Department of Clinical Chemistry and Hematology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Minerva Foundation Institute for Medical Research, Helsinki, Finland.

ORCID-Profile: Rafael Escate, Teresa Padró, Rosa Suades, Yvan Devaux, Päivi Lakkisto, Alessandro Sionis, Lina Badimon

Förderung

  • Agencia Estatal de Investigación
  • Instituto de Salud Carlos III
  • Spanish Society of Cardiology (SEC)
  • Sociedad Española de Cardiología

Zitieren

APA

Escate, R., Padró, T., Suades, R., Sans-Roselló, J., Devaux, Y., Lakkisto, P., Harjola, V. P., Sionis, A., & Badimon, L. (2024). miR ‐619‐5p and cardiogenic shock in patients with ST‐segment elevation myocardial infarction. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14186

Vancouver

Escate R, Padró T, Suades R, Sans-Roselló J, Devaux Y, Lakkisto P, et al. miR ‐619‐5p and cardiogenic shock in patients with ST‐segment elevation myocardial infarction. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14186

BibTeX
@article{Escate2024,
  author = {Escate, Rafael and Padró, Teresa and Suades, Rosa and Sans-Roselló, Jordi and Devaux, Yvan and Lakkisto, Päivi and Harjola, Veli-Pekka and Sionis, Alessandro and Badimon, Lina},
  title = {miR ‐619‐5p and cardiogenic shock in patients with ST‐segment elevation myocardial infarction},
  journal = {European Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1111/eci.14186}
}
Kostenlos starten →